See also this year's filing and all EDGAR filings for this company.
PDF Report 0001502152_2021_Globestar_Therapeutics_Corp.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Expenses', 'value': 9801628, 'size_variable': 'Assets', 'size_value': 5960, 'ratio': 1644.6, 'threshold': 20} |
Graph
Absolute values for 0001502152, Globestar Therapeutics Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 88,637 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,275 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 749,134 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 2,897 |
| 8 | SellingGeneralAndAdministrativeExpense | 269,054 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 281,563 |
| 11 | remainder_Revenues | 112 |
| 12 | remainder_NetIncome | 578 |
| 13 | remainder_ComprehensiveNetIncome | 109 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 89,912 |
| 1 | Liabilities | 749,134 |
| 2 | Expenses | 553,514 |
| 3 | Revenues | 112 |
| 4 | StockholdersEquity | -659,222 |
| 5 | NetIncome | -552,824 |
| 6 | ComprehensiveNetIncome | -552,770 |
| 7 | BaseVar | 696,680 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.74 |
| 9 | EconomicCapitalRatio | 0.233 |
Edgar->Model Mapping
Feature Distribution
Change over Time
